Angelman Syndrome Foundation (ASF): Research Grants

Funds groundbreaking scientific research that brings us closer to effective treatments and improved care for individuals with Angelman syndrome (AS). The call for research proposals invites scientists and clinicians worldwide to submit innovative studies that align with 2025 ASF Research Roadmap and priorities:

* UBE3A Regulation and Function – rigorous research towards understanding how UBE3A expression is regulated and how UBE3A functions in protein homeostasis and in neuronal function.

* Cutting Edge Therapeutic Strategies – study and development of new therapeutic approaches and the translational

studies required for their advancement to the clinic.

* Clinical Care and Innovation – Enhance the quality of life and well-being of individuals with Angelman Syndrome through comprehensive and personalized clinical care approaches.

* Therapeutic Endpoints and Biomarkers – explore and develop endpoints and biomarkers to improve clinical

trial design and measurement of response beyond physician and caregiver reported measures.  Establish objective measures of treatment response and disease progression to facilitate the evaluation of therapeutic interventions for Angelman Syndrome.

Funding: up to $100,000/year for up to 2 years.

https://angelman.org/call-for-proposals/